Hepatitis C virus infection in special groups

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 130-135

  Zoulim, Fabien ^a,b  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

Author keywords

Haemodialysis; Haemophilia; Hepatitis C; Transplantation

Indexed keywords

BLOOD TRANSFUSION; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; HEMODIALYSIS; HEMOPHILIA; HEPATITIS C; HUMAN; HYPOGAMMAGLOBULINEMIA; INFECTION RISK; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SUPERINFECTION; THALASSEMIA;

EID: 0033405726     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(99)80389-4     Document Type: Conference Paper

References (34)

1. Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Rizza CR, Dusheiko GM et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997: 350: 1425-1431.
2. Tuveri R, Rothschild C, Pol S, Reijasse D, Persico T, Gazengel C et al. Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections. J Med Virol 1997: 51: 36-41.
3. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994: 343: 388-390.
4. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M. Superinfection of chimpanzees carrying hepatitis C virus of genotype Il/lb with that of genotype III/2a or I/la. Hepatology 1994: 20: 1131-1136.
5. Taliani G, Guerra E, Rosso R, Badolato M, Luzi G, Sacco G et al. Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin. Transfusion 1995: 35: 103-107.
6. Rossi G, Tucci A, Cariani E, Ravaggi A, Rossini A, Radaeli E. Outbreak of hepatitis C virus infection in patients with hématologie disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. Blood 1997: 90: 1309-1314.
7. Christie J, Healey C, Watson J, Wong V, Duddridge M, Snowden N et al. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up. Clin Exp Immunol 1997: 110: 4-8.
8. Booth J, Kumar U, Webster D, Monjardino J, Thomas H. Comparison of the rate of sequence variation in the hypcrvariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 1998: 27: 223-227.
9. Wreghitt TO, Gray JJ, Allain JP, Poulain J, Garson JA, Deaville R et al. Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol 1994: 20: 768-772.
10. Michallet M, Moullet I, Archimbaud E, Tardy JC, Dhedin N, Belhabri A et al. Retrospective study of hepatitis C virus infection in 244 patients undergoing allogeneic bone marrow transplant (1980 to 1993). Blood 1995: 86 (suppl 1): 855a.
11. Strasser SI, Spurgeon CL, Kirn S, Schoch HO, Myerson D, Sullivan KM et al. Hepatitis C virus infection and bone marrow transplantation : a prospective study with 10 year follow-up. Hepatology 1998: 28 (Pt2): abstract 453.
12. Locasciulli A, Testa M, Pontisso P, Bacigalupo A, Ljungman P, Frickhofen N et al. Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1997: 19: 237-240.
13. Zein NN, McGreger CG, Wendt NK, Schwab K, Mitchell PS, Persing DH et al. Prevalence and outcome of hepatitis C virus infection among heart transplant recipients. J Heart Lung Transplant 1995: 14: 865-869.
14. Kroes AC, de Man RA, Niesters HG, Schalm SW, Weimar W, Balk AH. Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only. J Hepatol 1994:21: 1113-1115.
15. Baril G. Prevalence of hepatitis C virus in dialysis in Spain. Nephrol Dial Transplant 1993: 8: 966.
16. Schneeberger PM, Keur I, van der Vliet W, van Hoek K, Boswijk K, van Loon AM et al. Hepatitis C virus infections in dialysis centers in the Netherlands: a national survey by serological and molecular methods. J Clin Microbiol 1998: 36: 1711-1715.
17. Hinrichsen H, Schrader H, Steegen G, Leimenstoll G, Fölsch DR, Schmidt WE. Prevalence of hepatitis C in hemodialysis patients: viremia without detectable levels of HCV-antibodies. Hepatology 1998: 28 (Pt2): abstract 1631.
18. Jadoul M. Transmission routes of HCV infection in dialysis. Nephrol Dial Transplant 1996: 11 (suppl 4): 36-38.
19. Chauveau P. Epidemiology of hepatitis C virus infection in chronic haemodialysis. Nephrol Dial Transplant 1996: 11 (suppl 4): 391.
20. Haem J, Berthoux P, Cécillon S, Mosnier JF, Pozzetto B, Berthoux F. HCV liver disease in renal transplantation: a clinical and histological study. Nephrol Dial Transplant 1996: 11 (suppl 4): 48-51.
21. Hammoud H, Haem J, Laurent B, Alamartine E, Diab N, Defil-ippis JP et al. Glomerular disease during HCV infection in renal transplant. Nephrol Dial Transplant 1996: 11 (Suppl 4): 54-55.
22. Hanafusa T, Ichikawa Y, Kishikawa H, Kyo M, Fukunishi T, Kokado Y et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998: 66: 471-476.
23. Pcreira BJ, Natov SN, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998: 53: 1374-1381.
24. Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999: 29: 257-263.
25. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998: 28: 27-33.
26. Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA et al. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 1997: 80: 2060-2067.
27. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in Huh7 cells. J Virol 1993: 67: 5823-5832.
28. Kew MC, Yu MC, Kedda MA, Coppin A, Sarkin A, Hodkinson J. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology 1997: 112: 184-187.
29. Ruiz J, Sangro B, Cuende J, Beloqui O, Riezu-Boj JI, Herrero JI et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992: 16: 637-641.
30. Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993: 18: 1326-1333.
31. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997: 336: 747-754.
32. Tanaka E, Alter HJ, Nakatsuji Y, Shih JW, Kim JP, Matsumoto A et al. Effect of hepatitis G virus infection in chronic hepatitis C. Ann Intern Med 1996: 125: 740-743.
33. Martinet M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-or in patients with chronic hepatitis C. Ann Intern Med 1997: 126: 874-881.
34. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N End J Med 1998: 338: 286-290.